Coeptis Therapeutics Inc. Quarterly Interest Expense in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Coeptis Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q3 2022.
  • Coeptis Therapeutics Inc. Interest Expense for the quarter ending September 30, 2022 was $56.4K, a 70.1% decline year-over-year.
  • Coeptis Therapeutics Inc. Interest Expense for the twelve months ending September 30, 2022 was $96.8K, a 39.4% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Interest Expense for 2021 was $187K, a 26.3% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $96.8K $56.4K -$132K -70.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $229K $63.8K +$20.7K +48.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $208K $55.8K +$21.1K +60.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $187K -$79.3K +$27.3K +25.6% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $160K $189K +$4.69K +2.55% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $155K $43.1K +$6.76K +18.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $148K $34.7K +$237 +0.69% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $148K -$107K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $184K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $36.3K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $34.5K Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.